Literature DB >> 9070264

Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7.

Z Liu1, M G Brattain, H Appert.   

Abstract

Matrigel invasion assays were used to characterize the invasive abilities of five breast cancer cell lines. Reverse Transcription Polymerase Chain Reaction (RT-PCR) was used to detect the differential gene expression of estrogen receptor (ER), E-cadherin, vimentin and cathepsin D in these cell lines. Using mRNA differential display, we identified novel cDNA clones representing the partial sequences of genes overexpressed in the invasive MDA-MB-435 cells as compared to that of the less invasive MCF-7 cells. One of the cDNAs was homologous to reticulocalbin. The studies were repeated in all of the cell lines and the overexpression of this cDNA was confirmed by RT-PRC and Northern hybridization analysis. Reticulocalbin was expressed in the highly invasive breast cancer cell lines but was not expressed in poorly invasive ones. Although its function is still unknown, reticulocalbin is implicated in tumor cell invasiveness because of its differential expression in breast tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070264     DOI: 10.1006/bbrc.1997.6083

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  Endonuclease G promotes cell death of non-invasive human breast cancer cells.

Authors:  Alexei G Basnakian; Eugene O Apostolov; Xiaoyan Yin; Stanley O Abiri; Anna G Stewart; Amar B Singh; Sudhir V Shah
Journal:  Exp Cell Res       Date:  2006-09-20       Impact factor: 3.905

2.  BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor.

Authors:  L Zheng; L A Annab; C A Afshari; W H Lee; T G Boyer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

3.  Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.

Authors:  D Ding; H Huang; W Jiang; W Yu; H Zhu; J Liu; H Saiyin; J Wu; H Huang; S Jiang; L Yu
Journal:  Oncogene       Date:  2017-07-24       Impact factor: 9.867

4.  Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer.

Authors:  Gang Wang; Qian Wang; Yongguo Fan; Xianli He
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

5.  Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.

Authors:  D K Biswas; L Averboukh; S Sheng; K Martin; D S Ewaniuk; T F Jawde; F Wang; A B Pardee
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

6.  Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.

Authors:  Weiguo Wu; Ximing Tang; Wei Hu; Reuben Lotan; Waun Ki Hong; Li Mao
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

7.  Calumenin but not reticulocalbin forms a Ca2+-dependent complex with thrombospondin-1. A potential role in haemostasis and thrombosis.

Authors:  Gry Aune Westergaard Hansen; Henrik Vorum; Christian Jacobsen; Bent Honoré
Journal:  Mol Cell Biochem       Date:  2008-08-08       Impact factor: 3.396

8.  Proteomic analysis of human bone marrow mesenchymal stem cells transduced with human telomerase reverse transcriptase gene during proliferation.

Authors:  G P Huang; Z J Pan; J P Huang; J F Yang; C J Guo; Y G Wang; Q Zheng; R Chen; Y L Xu; G Z Wang; Y M Xi; D Shen; J Jin; J F Wang
Journal:  Cell Prolif       Date:  2008-06-19       Impact factor: 6.831

9.  A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1.

Authors:  P Y Desprez; C Q Lin; N Thomasset; C J Sympson; M J Bissell; J Campisi
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

10.  Salivary NUS1 and RCN1 Levels as Biomarkers for Oral Squamous Cell Carcinoma Diagnosis.

Authors:  Sei Ueda; Kengo Hashimoto; Satoru Miyabe; Shogo Hasegawa; Mitsuo Goto; Dai Shimizu; Ichiro Oh-Iwa; Kazuo Shimozato; Toru Nagao; Shuji Nomoto
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.